Nexus Venture Partners

“In The Age of AI, Everything is an API!" Watch Postman Co-Founder & CEO Abhinav Asthana and Nexus Venture Partners MD Jishnu B. in an exclusive conversation with Shereen Bhan, Managing Editor, CNBC-TV18. https://lnkd.in/gymvTRRm

We're delighted to co-lead Rocketlane's Series B, deepening our partnership with this B2B SaaS leader! The phenomenal team is ready to transform client project delivery with its powerful AI-first roadmap while serving a rapidly growing customer base worldwide. Huge congrats to Srikrishnan Ganesan, Vignesh Girishankar, Deepak Bala, and the entire team! Jishnu B., Sameer Brij Verma, Arjun Gandhi https://lnkd.in/gsq7ShsW

Congratulations Aadit Palicha, Kaivalya V. and the team at Zepto on an important milestone. Honoured to be partners since inception. Suvir Sujan 🔗 https://lnkd.in/gwv8zrpw

We are thrilled to continue backing the Iambic team led by Thomas Miller and Fred Manby. Iambic Therapeutics is making a remarkable impact at the intersection of AI and medicine. “Iambic’s novel generative AI platform for drug development with demonstrated ability to discover drug molecules and advance them to clinical trials is unmatched in the industry," said Jishnu B., MD, Nexus, as he expressed his confidence in Iambic's journey ahead. Congratulations to Iambic on closing the latest funding round! https://lnkd.in/eQk6jD96

Founded in a lab at Indian Institute of Technology, Bombay, we are thrilled to have been early partners with SEDEMAC and to watch the company build a Global IP from India. Shashikanth Suryanarayanan | Amit Dixit | Manish Sharma | Sandeep Singhal 🔗 https://lnkd.in/daknEcrJ

Puneet Kumar just joined the team, and we're stoked to have him on board! Join us in welcoming him.

We're thrilled to welcome Triomics, a novel Generative AI platform dedicated to empowering cancer care providers, to the Nexus family! Triomics leverages their proprietary OncoLLM™ models, to unlock the power of unstructured medical data in patient records. This translates to: → Faster analysis of vast amounts of free-text data → Efficient matching of patients to potentially life-saving clinical trials → Streamlined care operations for improved quality and efficiency → Precision oncology: delivering the right treatments to the right patients Their impressive early results and collaborations with leading cancer centers position Triomics to make a significant global impact in the fight against cancer. We're incredibly proud to partner with Sarim Khan and Hrituraj Singh, the brilliant minds behind Triomics, and support them in building a company that will truly change lives. Jishnu B. https://lnkd.in/gjytiJkg

I am so proud of the community and the team behind ZITADEL to reach these important milestones! 🚀 Special thanks also to Abhishek Sharma from Nexus Venture Partners for believing in us and being a great sparing partner for our journey 🙏

Congrats, Thomas, Daniel, Jie, and the amazing Daloopa team on Series B 🚀! Welcoming Priya Saiprasad / Touring Capital team and Morgan Stanley! It’s a privilege for us at Nexus Venture Partners to have been part of the Daloopa journey since day 0. We are proud to double down in this round and continue our support. Daloopa uses #AI as a wedge to disrupt the multi-billion-dollar #financialdata space. Daloopa’s innovative AI-powered approach bridges the gap between the reporting of financial data at source and its consumption in financial analyst workflows. We’re excited that Daloopa is rapidly becoming the must-have tool for financial analysts.